Back to Search

KATHERINE PRICE, MD

MD

Pulmonary Disease Physician

NPI: 1275824427IndividualAccepts Medicare

Specialties, Licenses & Credentials

Critical Care Medicine (Internal Medicine) Physician

Internal Medicine — Critical Care Medicine

Code: 207RC0200X

0101262121(VA)
Pulmonary Disease PhysicianPrimary

Internal Medicine — Pulmonary Disease

Code: 207RP1001X

0101262121(VA)

CMS Specialties

PrimaryPULMONARY DISEASE

Education

VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE

Class of 2011

Research & Publications (20)

Clinical trial update: International Breast Cancer Study Group.
PMID 16280051·Breast Cancer Res·2005
8-other
CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13.
PMID 12654630·Am J Respir Cell Mol Biol·2003
8-other
Job satisfaction and burnout among staff working in community-based personality disorder services.
PMID 19592446·Int J Soc Psychiatry·2010
8-other
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.
PMID 19280340·Breast Cancer Res Treat·2010
4-observational
Factors associated with anemia in patients with cancer admitted to an intensive care unit.
PMID 19577413·J Crit Care·2010
8-other
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
PMID 19633051·Ann Oncol·2010
4-observational
Self-reported adverse events in health care that cause harm: a population-based survey.
PMID 19413518·Med J Aust·2009
8-other
Identifying unit-specific nursing demands using Nursing Interventions Classification (NIC).
PMID 19592973·Stud Health Technol Inform·2009
8-other
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
PMID 19474112·Ann Oncol·2009
3-trial
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
PMID 19468030·Ann Oncol·2009
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
13551 WATERFORD PL
MIDLOTHIAN, VA 23112

Quick Facts

NPI
1275824427
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
15
Publications
20

Are you this provider?

Claim Your Profile